Melanocortin interventions in cachexia: how soon from bench to bedside?
- 1 July 2007
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Clinical Nutrition and Metabolic Care
- Vol. 10 (4) , 457-462
- https://doi.org/10.1097/mco.0b013e328108f441
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Mechanisms of Disease: cytokine and adipokine signaling in uremic cachexiaNature Clinical Practice Nephrology, 2006
- Symptom patterns of advanced cancer patients in a palliative care unitPalliative Medicine, 2006
- Therapy insight: use of melanocortin antagonists in the treatment of cachexia in chronic diseaseNature Clinical Practice Endocrinology & Metabolism, 2006
- Anorexia in hemodialysis patients: An updateKidney International, 2006
- Cachexia: lessons from melanocortin antagonismTrends in Endocrinology & Metabolism, 2006
- Longitudinal Associations Between Dietary Protein Intake and Survival in Hemodialysis PatientsAmerican Journal of Kidney Diseases, 2006
- Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosisThe American Journal of Clinical Nutrition, 2006
- Prognosis and therapy approaches of cardiac cachexiaCurrent Opinion in Cardiology, 2006
- Clinical Anticachexia TreatmentsNutrition in Clinical Practice, 2006
- Systemic inflammation, cachexia and prognosis in patients with cancerCurrent Opinion in Clinical Nutrition and Metabolic Care, 2005